Home › Funds › Point72 Asset Management › EPRX
Point72 Asset Management position in EPRX
EUPRAXIA PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)730.28K sh
Reported value held$4.83M
Portfolio Weight0.01%
First reportedQ4 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 712.10K | $5.38M | New |
| Q1 2026 | 967.58K | $7.01M | Add |
| Q2 2026 | 730.28K | $4.83M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding EPRX
- Balyasny Asset Management 1.35M sh · $8.92M · Q2 2026
- UBS Group AG 519.21K sh · $3.43M · Q2 2026
- Citadel Advisors 502.01K sh · $3.32M · Q2 2026
- Millennium Management 441.59K sh · $2.92M · Q2 2026
- Bank of America Corp 264.72K sh · $1.75M · Q2 2026
- Two Sigma Investments 221.08K sh · $1.46M · Q2 2026
- Marshall Wace 158.13K sh · $1.05M · Q2 2026
- Goldman Sachs Group 58.06K sh · $383.76K · Q2 2026
- Geode Capital Management 36.21K sh · $239.35K · Q2 2026
- JPMorgan Chase & Co 14.19K sh · $93.49K · Q2 2026
- BlackRock Inc 6.09K sh · $40.24K · Q2 2026